|
|
||||||||
Center for Radiopharmaceutical Science, Paul Scherrer Institute, Villigen-PSI, Switzerland
Forschungszentrum Rossendorf, Institut für Radiochemie, Dresden, Germany
Eenheid Organische Chemie Vrije Universiteit Brussel, Brussel, Belgium
Correspondence: For correspondence or reprints contact: André Egli, MD, Paul Scherrer Institute, Center for Radiopharmaceutical Science, Villigen-PSI CH-5232, Switzerland.
ABSTRACT
A new peptide labeling method that uses the organometallic aquaion [99mTc (H2O)3(CO)3]+ has been developed. Methods: A selection of amino acids was labeled at different concentrations with the organometallic aquaion, and the labeling yield was determined by high-performance liquid chromatography. This investigation has shown histidine to be a very potent ligand, with specific activities of up to 6 TBq/µmol (160 Ci/µmol) ligand. Histidine derivatives have been coupled to neurotensin (813) (NT[813]) and have been labeled with the aquaion, resulting in high specific activities with (N
-histidinyl)acetic acid-NT(813) similar to those with histidine. Results: Histidine derivatives of NT(813) labeled using this approach fully retained their receptor affinity, showing KD values of all investigated NT analogs below 1 nmol/L on colon carcinoma HT29 cells. Biodistribution experiments in BALB/c mice showed complete clearance of (N
-histidinyl) acetic acid-NT(813) from the blood after 24 h and no unwanted accumulation in any tissue. Conclusion: The novel labeling method using the organometallic 99mTc-aquaion combines the advantage of highest specific activities with minimal functionalization of proteins and peptides under retention of biologic affinity.
Key Words: peptides 99mTc neurotensin histidine
This article has been cited by other articles:
![]() |
M. Lipowska, H. He, E. Malveaux, X. Xu, L. G. Marzilli, and A. Taylor First Evaluation of a 99mTc-Tricarbonyl Complex, 99mTc(CO)3(LAN), as a New Renal Radiopharmaceutical in Humans J. Nucl. Med., June 1, 2006; 47(6): 1032 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Smith, G. L. Sieckman, N. K. Owen, D. L. Hayes, D. G. Mazuru, R. Kannan, W. A. Volkert, and T. J. Hoffman Radiochemical Investigations of Gastrin-releasing Peptide Receptor-specific [99mTc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, Tumor-bearing, Rodent Models: Syntheses, Radiolabeling, and in Vitro/in Vivo Studies where Dpr = 2,3-Diaminopropionic acid and X = H2O or P(CH2OH)3 Cancer Res., July 15, 2003; 63(14): 4082 - 4088. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |